Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The subcutaneous injections available in the United States are dulaglutide (Trulicity, Eli Lilly, for type 2 diabetes), liraglutide (Victoza, Novo Nordisk, for type 2 diabetes), semaglutide (Ozempic, Novo Nordisk, for type 2 diabetes and Wegovy, for weight loss), tirzepatide (Mounjaro, Eli Lilly, for type 2 diabetes), and Zepbound (Eli Lilly, for weight loss)
Ziltive kimab is an IL-6 monoclonal antibody specifically developed for cardiovascular risk reduction
Aged Garlic Extract Reduces Low Attenuation Plaque in Coronary Arteries of Patients with Metabolic Syndrome in a Prospective Randomized Double-Blind Study
Monitor Blood Sugar Levels (For Those With Diabetes or Insulin Resistance) Stopping GLP-1 receptor agonists may lead to increased blood sugar levels
US$ 20.47
US$ 28.88
US$ 25.02
US$ 21.66
US$ 27.07
US$ 27.65
US$ 22.35
US$ 24.81
US$ 22.31
US$ 25.70
US$ 22.09
US$ 29.14
